167 related articles for article (PubMed ID: 37668243)
1. Immune thrombocytopenia: a review on the pathogenetic role of immune cells.
Nokhostin F; Bakhshpour F; Pezeshki SMS; Khademi R; Saki N
Expert Rev Hematol; 2023; 16(10):731-742. PubMed ID: 37668243
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of immune thrombocytopenia.
Audia S; Mahévas M; Samson M; Godeau B; Bonnotte B
Autoimmun Rev; 2017 Jun; 16(6):620-632. PubMed ID: 28428120
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
4. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study.
Åkesson A; Bussel JB; Martin M; Blom AM; Klintman J; Ghanima W; Zetterberg E; Garabet L
Platelets; 2023 Dec; 34(1):2159019. PubMed ID: 36636835
[TBL] [Abstract][Full Text] [Related]
5. [Immune thrombocytopenia: From pathogenesis to treatment].
Audia S; Mahevas M; Bonnotte B
Rev Med Interne; 2021 Jan; 42(1):16-24. PubMed ID: 32741715
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
Wang L; Li Y; Hou M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
[TBL] [Abstract][Full Text] [Related]
7. Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.
Audia S; Mahévas M; Nivet M; Ouandji S; Ciudad M; Bonnotte B
Hemasphere; 2021 Jun; 5(6):e574. PubMed ID: 34095758
[TBL] [Abstract][Full Text] [Related]
8. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP.
Weitz IC; Liebman HA
Br J Haematol; 2023 Oct; 203(1):96-100. PubMed ID: 37735550
[TBL] [Abstract][Full Text] [Related]
9. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
10. [Recent progress in immune thrombocytopenia pathophysiology and treatment].
Kato H
Rinsho Ketsueki; 2023; 64(9):1106-1115. PubMed ID: 37899189
[TBL] [Abstract][Full Text] [Related]
11. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
13. Novel therapies for immune thrombocytopenia.
Kuter DJ
Br J Haematol; 2022 Mar; 196(6):1311-1328. PubMed ID: 34611885
[TBL] [Abstract][Full Text] [Related]
14. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated autoimmunity in immune thrombocytopenia.
Vrbensky JR; Nazy I; Clare R; Larché M; Arnold DM
Eur J Haematol; 2022 Jan; 108(1):18-27. PubMed ID: 34487584
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT.
Amin Asnafi A; Jalali MT; Pezeshki SMS; Jaseb K; Saki N
J Pediatr Hematol Oncol; 2019 Mar; 41(2):81-86. PubMed ID: 30543580
[TBL] [Abstract][Full Text] [Related]
18. Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura.
Shirota T; Yamamoto H; Fujimoto H; Harada Y; Okada K; Uchida H; Roppongi H; Hayashi T
Am J Hematol; 1997 Dec; 56(4):272-6. PubMed ID: 9395191
[TBL] [Abstract][Full Text] [Related]
19. Current approaches for the diagnosis and management of immune thrombocytopenia.
Gafter-Gvili A
Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
[TBL] [Abstract][Full Text] [Related]
20. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.
Chow L; Aslam R; Speck ER; Kim M; Cridland N; Webster ML; Chen P; Sahib K; Ni H; Lazarus AH; Garvey MB; Freedman J; Semple JW
Blood; 2010 Feb; 115(6):1247-53. PubMed ID: 20007808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
